Utility of a dipstick (Micraltest®) in the measurement of microalbuminuria as a marker of early nephropathy in diabetic type 2 and hypertensive patients.

被引：0
|
作者：
Cortes-Sanabria, L
Martinez-Ramirez, HR
Rojas-Campos, E
Hernandez, J
Navarro, BG
Cueto-Manzano, AM
机构：
[1] Inst Mexicano Seguro Social, Med Res Unit Clin Epidemiol, Guadalajara, Jalisco, Mexico
[2] IMSS, Hosp Especialidades, Guadalajara, Jalisco, Mexico
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：398A / 398A
页数：1
相关论文
共 50 条
  • [21] Cilostazol reduces microalbuminuria in type 2 diabetic nephropathy
    Jiao Xiu-min
    Jiao Xiu-juan
    Zhang Xing-guang
    Xu Xiu-ping
    Wu Jin-xiao
    Yao Lu
    Zhao Jing
    Lu Xiao-feng
    CHINESE MEDICAL JOURNAL, 2013, 126 (22) : 4395 - 4396
  • [22] suPAR as a marker of diabetic nephropathy in patients with type 2 diabetes
    Wang, Tao
    Zhang, Qingjuan
    Liu, Meng
    Lu, He
    Lu, Huan
    Zhu, Jiang
    Yuan, Zijing
    Li, Jianbo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (04): : 4218 - 4225
  • [23] Urinary immunoglobulin G versus microalbuminuria as an indicator of diabetic nephropathy in type 2 diabetic patients
    Nafesa M. Kamal
    Ahmed M. Elsayed
    Essam Amin
    Amal Zedan
    The Egyptian Journal of Internal Medicine, 2018, 30 (2) : 58 - 62
  • [24] LIPIDS AND DIABETIC NEPHROPATHY - HYPERTENSION, MICROALBUMINURIA AND LIPIDS IN TYPE-2 DIABETIC-PATIENTS
    MANZATO, E
    ZAMBON, S
    CORTELLA, A
    SARTORE, G
    NOSADINI, R
    CREPALDI, G
    ACTA DIABETOLOGICA, 1992, 29 (3-4) : 231 - 233
  • [25] Relationship between Oxidant/Antioxidant Markers and Severity of Microalbuminuria in the Early Stage of Nephropathy in Type 2 Diabetic Patients
    Shao, Ning
    Kuang, Hong Yu
    Wang, Na
    Gao, Xin Yuan
    Hao, Ming
    Zou, Wei
    Yin, Hui Qing
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
  • [26] Prevalence of microalbuminuria in type 2 diabetic hypertensive patients in France (microalb study)
    Laville, M.
    Krempf, M.
    Om, S.
    Denolle, T.
    JOURNAL OF HYPERTENSION, 2006, 24 : S100 - S100
  • [27] Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients
    Fogari, R
    Preti, P
    Zoppi, A
    Rinaldi, A
    Corradi, L
    Pasotti, C
    Poletti, L
    Marasi, G
    Derosa, G
    Mugellini, A
    Voglini, C
    Lazzari, P
    AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (12) : 1042 - 1049
  • [28] Microalbuminuria as early indicator of left ventricular hypertrophy in non hypertensive, type-1-and-2 diabetic patients
    Petit, Y
    Contreras, FO
    Lara, A
    Díaz, G
    Verde, O
    Fouillioux, CF
    Velasco, M
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 133A - 133A
  • [29] Microalbuminuria as an early indicator of left ventricular hypertrophy in non hypertensive, type-1-and-2 diabetic patients
    Petit, Y
    Contreras, FO
    Lara, A
    Díaz, G
    Verde, O
    Fouillioux, CF
    Velasco, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1068 - 1068
  • [30] Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy
    Fukuda, Akihiro
    Minakawa, Akihiro
    Kikuchi, Masao
    Sato, Yuji
    Nagatomo, Masanao
    Nakamura, Shuji
    Mizoguchi, Tetsu
    Fukunaga, Naoya
    Shibata, Hirotaka
    Naik, Abhijit S.
    Wiggins, Roger C.
    Fujimoto, Shouichi
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345